Innovation Pharmaceuticals Inc (IPIX)

[MinnieM]

We don't know what the EU will require. The Brilacidin UP enema may be akin to the Brilacidin OM rinse in that mucousa is being "rinsed" in both cases. OM didn't show any systemic issues. The EU may allow a ph3 with an interim required. I'd love to hear from one of the scientists or Dr's on this.

The EU may allow the OM patient numbers to look at safety issues. Is this a stretch or realistic... kind of thinking/typing out loud. Hmmmm

Any thoughts?

Either way, Alfasigma has the funds, staff and experience to push this all through fairly quickly. Plus, we still may have another deal coming up for Brilacidin OM. This is why I'm not as concerned about upfront dollars as others are. Our next deal should be superior to the first.

As I've already said, I'm happy for a global pharma to have validated Brilacidin and IPIX via a licensing agreement. And, we now have proof that Leo spoke truth when saying he had a signed term sheet.





In Reply to 'loanranger'
But this is a very serious issue isn't it?

"UP is not a phase 3 ready drug..........Alfa will run a phase 2a for UP"

Other than the mysterious initial payment and the MFO deal there's no scheduled source of cash until that Phase 3 starts. If he's right then that just got pushed back by whatever length of time a P2a and the attendant festivities take.